INCYTE CORP is 2.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($21.23 B vs $8.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INCY | CRL |
|---|---|---|
| Market cap | $21.23 B | $8.97 B |
| US-listed rank | #595 | #1006 |
| Revenue (latest FY) | $5.14B | $4.02B |
| Net income (latest FY) | $1.29B | -$144.34M |
| Net margin | 25.0% | -3.6% |
| P/E (trailing FY) | 16.5 | - |
| SEC filings | 2,536 | 2,387 |
INCYTE CORP is 2.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($21.23 B vs $8.97 B).
In their latest fiscal years, INCYTE CORP reported $5.14B in revenue while CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B.
Full pages: INCYTE CORP and CHARLES RIVER LABORATORIES INTERNATIONAL, INC., or browse the full rankings.